Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
This trial is designed to test the efficacy of fluoxetine to improve patient's quality of
life during chemotherapy. An innovative application of a selective serotonin reuptake
inhibitor may modulate the effects of fatigue, anxiety and depression which worsen quality of
life.